MCID: CYS005
MIFTS: 57

Cysticercosis

Categories: Rare diseases, Infectious diseases, Neuronal diseases, Gastrointestinal diseases

Aliases & Classifications for Cysticercosis

MalaCards integrated aliases for Cysticercosis:

Name: Cysticercosis 12 49 55 51 3 41 14 69
Neurocysticercosis 12 72 49 51 3 69
Submacular Cysticercosis 49 69
Intestinal Taenia Solium Infection 12
Tenia Solium Infectious Disease 12
Pork Tapeworm Infection 12
Tenia Solium Infection 69
Taeniasis 49

Characteristics:

Orphanet epidemiological data:

55
cysticercosis
Inheritance: Not applicable; Age of onset: All ages;

Classifications:

Orphanet: 55  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:10079
ICD10 32 B69 B69.9
ICD9CM 34 123.1
MeSH 41 D003551
NCIt 46 C34520
Orphanet 55 ORPHA1560
MESH via Orphanet 42 D003551
UMLS via Orphanet 70 C0010678
ICD10 via Orphanet 33 B69.0 B69.1 B69.8 more

Summaries for Cysticercosis

NIH Rare Diseases : 49 Cysticercosis is an infection caused by the pork tapeworm, Taenia solium. The condition develops when tapeworm eggs, which can be found in contaminated food, enter the body and form cysticeri (cysts). In most cases, the worms stay in the muscles and do not cause symptoms. However, symptoms may be present when the infection is found in the brain, eyes, heart or spine. Although rare in the United States, cysticercosis is common in many developing countries. Treatment may include medications to kill the parasites and powerful anti-inflammatory medications (steroids) to reduce swelling. In severe cases, surgery may be needed to remove the infected area. Last updated: 3/20/2017

MalaCards based summary : Cysticercosis, also known as neurocysticercosis, is related to anterior uveitis and echinococcosis. An important gene associated with Cysticercosis is TLR4 (Toll Like Receptor 4), and among its related pathways/superpathways are Influenza A and RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways. The drugs Albendazole and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and heart, and related phenotypes are homeostasis/metabolism and immune system

CDC : 3 Cysticercosis is a parasitic tissue infection caused by larval cysts of the tapeworm Taenia solium. These larval cysts infect brain, muscle, or other tissue, and are a major cause of adult onset seizures in most low-income countries. A person gets cysticercosis by swallowing eggs found in the feces of a person who has an intestinal tapeworm.  People living in the same household with someone who has a tapeworm have a much higher risk of getting cysticercosis than people who don’t.

Disease Ontology : 12 A taeniasis that results from ingestion of eggs or larvae of the Taenia solium tapeworm in undercooked pork or fecally contaminated food or water, which subsequently infect the central nervous system, heart, muscles, subcutaneous tissues, and eyes. Neurocysticercosis causes seizures, mental disturbances, focal neurologic deficits and intracerebral lesions.

Wikipedia : 72 Neurocysticercosis is a specific form of the infectious parasitic disease cysticercosis which is caused... more...

Related Diseases for Cysticercosis

Diseases related to Cysticercosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 175)
# Related Disease Score Top Affiliating Genes
1 anterior uveitis 30.0 IL6 TLR4
2 echinococcosis 30.0 IL6 MT-CO1 MT-ND1
3 toxoplasmosis 29.8 IL1B IL6 TLR4
4 salmonellosis 29.8 IL18 IL1B TLR4
5 lymphadenitis 29.8 IL18 IL1B TLR4
6 taeniasis 29.6 MT-CO1 MT-ND1 RTP1 TACSTD2
7 chagas disease 29.6 IL12B IL1B IL6 TLR4
8 cystic echinococcosis 29.1 MT-CO1 MT-ND1
9 coenurosis 28.6 MT-CO1 MT-ND1 TACSTD2
10 prosthetic joint infection 10.5 IL1B TLR4
11 recurrent corneal erosion 10.5 IL1B IL6
12 bagassosis 10.5 IL1B IL6
13 periodontitis, chronic 10.5 IL1B IL6
14 funisitis 10.4 IL1B IL6
15 suppurative otitis media 10.4 IL1B TLR4
16 euthyroid sick syndrome 10.4 IL1B IL6
17 campylobacteriosis 10.4 IL1B TLR4
18 laryngitis 10.4 IL1B IL6
19 systemic onset juvenile idiopathic arthritis 10.4 IL18 IL1B
20 ascaris lumbricoides infection 10.4 IL1B IL6
21 acute vascular insufficiency of intestine 10.4 IL1B IL6
22 schnitzler syndrome 10.4 IL18 IL1B
23 poems syndrome 10.4 IL1B IL6
24 burning mouth syndrome 10.4 IL1B IL6
25 rheumatoid arthritis, systemic juvenile 10.4 IL6 MIF
26 endometrial disease 10.4 IL1B IL6 TLR4
27 central nervous system vasculitis 10.4 IL1B IL6
28 perinatal necrotizing enterocolitis 10.4 IL1B IL6 TLR4
29 uterine anomalies 10.4 IL1B IL6 TLR4
30 keratoconjunctivitis sicca 10.3 IL1B IL6 TLR4
31 bacterial vaginosis 10.3 IL1B IL6 TLR4
32 idiopathic neutropenia 10.3 IL1B IL6 TLR4
33 osteosclerotic myeloma 10.3 IL1B IL6
34 pyelonephritis 10.3 IL1B IL6 TLR4
35 typhoid fever 10.3 IL1B IL6 TLR4
36 aggressive periodontitis 10.3 IL1B IL6 TLR4
37 chorioamnionitis 10.3 IL1B IL6 TLR4
38 primary bacterial infectious disease 10.3 IL1B IL6 TLR4
39 chlamydia 10.3 IL1B IL6 TLR4
40 gastroschisis 10.3 IL1B IL6
41 toxic shock syndrome 10.3 IL1B IL6 TLR4
42 intestinal disease 10.3 IL1B IL6 TLR4
43 otitis media 10.3 IL1B IL6 TLR4
44 respiratory system disease 10.3 IL1B IL6 TLR4
45 bacteriuria 10.3 IL18 IL6 TLR4
46 periodontitis 10.3 IL1B IL6 TLR4
47 vaginal disease 10.3 IL1B IL6
48 paracoccidioidomycosis 10.3 IL18 IL6 TLR4
49 keratitis, hereditary 10.3 IL1B MIF TLR4
50 melioidosis 10.3 IL18 IL6 TLR4

Graphical network of the top 20 diseases related to Cysticercosis:



Diseases related to Cysticercosis

Symptoms & Phenotypes for Cysticercosis

MGI Mouse Phenotypes related to Cysticercosis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.85 IL12B IL18 IL1B IL6 MIF MT-CO1
2 immune system MP:0005387 9.61 IL12B IL18 IL1B IL6 MIF MT-CO1
3 neoplasm MP:0002006 9.17 IL12B IL1B IL6 MIF PDCD1LG2 TACSTD2

Drugs & Therapeutics for Cysticercosis

Drugs for Cysticercosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 39)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Albendazole Approved, Vet_approved Phase 3,Phase 2 54965-21-8 2082
2
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
3
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
4
Praziquantel Approved, Investigational, Vet_approved Phase 2, Phase 3 55268-74-1 4891
5
Acetazolamide Approved, Vet_approved Phase 2, Phase 3 59-66-5 1986
6
Benzocaine Approved, Investigational Phase 3 1994-09-7, 94-09-7 2337
7 tannic acid Approved, Nutraceutical Phase 3
8 Anthelmintics Phase 3,Phase 2,Phase 1
9 Anti-Infective Agents Phase 3,Phase 2,Phase 1
10 Antimitotic Agents Phase 3,Phase 2
11 Antiparasitic Agents Phase 3,Phase 2,Phase 1
12 Antiprotozoal Agents Phase 3,Phase 2
13 Antacids Phase 3
14 Antiemetics Phase 3,Phase 2
15 Anti-Inflammatory Agents Phase 3,Phase 2
16 Antineoplastic Agents, Hormonal Phase 3,Phase 2
17 Anti-Ulcer Agents Phase 3
18 Autonomic Agents Phase 3,Phase 2
19 BB 1101 Phase 3,Phase 2
20 Dexamethasone acetate Phase 3,Phase 2 1177-87-3
21 Gastrointestinal Agents Phase 3,Phase 2
22 glucocorticoids Phase 3,Phase 2
23 HIV Protease Inhibitors Phase 3,Phase 2
24 Hormone Antagonists Phase 3,Phase 2
25 Hormones Phase 3,Phase 2
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
27 Peripheral Nervous System Agents Phase 3,Phase 2
28
protease inhibitors Phase 3,Phase 2
29 Proton pump inhibitors Phase 3
30 Anticonvulsants Phase 2, Phase 3
31 Carbonic Anhydrase Inhibitors Phase 2, Phase 3
32 diuretics Phase 2, Phase 3
33 Natriuretic Agents Phase 2, Phase 3
34 Benzimidazole Experimental, Investigational Phase 1 51-17-2
35
Oxfendazole Phase 1 53716-50-0 40854
36
Phenytoin Approved, Vet_approved 57-41-0 1775
37 Niclosamide Approved, Investigational, Vet_approved 50-65-7 4477
38 Diuretics, Potassium Sparing
39 Sodium Channel Blockers

Interventional clinical trials:

(show all 20)

# Name Status NCT ID Phase Drugs
1 Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT Completed NCT02243644 Phase 3 7 days of albendazole 15 mg/kg/day;28 days of albendazole 15 mg/kg/day
2 A Pilot Study of Neurocysticercosis Treatment Completed NCT00283699 Phase 3 albendazole
3 Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients Completed NCT00290823 Phase 3 Albendazole;Dexamethasone;Omeprazole
4 Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) Completed NCT00441285 Phase 2, Phase 3 Praziquantel;Albendazole;ABZ Placebo;PZQ Placebo
5 Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) Recruiting NCT02945527 Phase 2, Phase 3 Acetazolamide;Dexamethasone
6 Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) Not yet recruiting NCT02947581 Phase 3 Albendazole and praziquantel;Albendazole and praziquantel placebo
7 RCT ALB for SA Cysticercosis Withdrawn NCT00133458 Phase 3 Albendazole
8 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Completed NCT00527579 Phase 1 [F-18]FBR
9 PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Completed NCT00526916 Phase 1 [C-11]PBR28
10 Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole Completed NCT02234570 Phase 1 Oxfendazole
11 Single Ascending Dose Safety Study of Oxfendazole Withdrawn NCT01584362 Phase 1 oxfendazole;placebo;oxfendazole;oxfendazole;oxfendazole;oxfendazole;oxfendazole
12 EFECAB: Improving Pig Management to Prevent Epilepsy in Burkina Faso Completed NCT03095339
13 Brain Tissue Swelling and Seizure Activity in Inactive Cysticercosis Completed NCT00001912
14 Taenia Solium Control Case Study in Zambia Completed NCT01368354
15 Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis Completed NCT00004403 albendazole;dexamethasone;phenytoin
16 Targeted Screening for Taenia Solium Tapeworms Completed NCT01296958 Niclosamide
17 Treatment of Patients With Cysticercosis With Praziquantel or Albendazole Recruiting NCT00001205
18 Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa? Recruiting NCT02612896 Mass drug administration, praziquantel 10mg/kg
19 People Presenting With Neurocysticercosis in North America Terminated NCT02233855
20 Mass Treatment T Solium Community Study Terminated NCT00138359 Niclosamide

Search NIH Clinical Center for Cysticercosis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: cysticercosis

Genetic Tests for Cysticercosis

Anatomical Context for Cysticercosis

MalaCards organs/tissues related to Cysticercosis:

38
Brain, Eye, Heart, Testes, Tongue, Breast, Spinal Cord

Publications for Cysticercosis

Articles related to Cysticercosis:

(show top 50) (show all 748)
# Title Authors Year
1
Prevalence of cysticercosis in Estonian pigs and cattle. ( 29230579 )
2018
2
Seroprevalence of human cysticercosis in JataA-, GoiA!s state, Brazil. ( 29432711 )
2018
3
Subretinal cysticercosis with a mobile scolex. ( 29437748 )
2018
4
Cysticercosis and cytodiagnosis. ( 29193889 )
2018
5
Disseminated cysticercosis presenting as status epilepticus, rhabdomyolysis, and acute kidney injury: An unreported complication. ( 29322996 )
2018
6
Extraocular muscle cysticercosis: never skip steroids. ( 29321202 )
2018
7
Neurocysticercosis among People Living Near Pigs Heavily Infected with Cysticercosis in Rural Endemic Peru. ( 29210354 )
2018
8
Low sensitivity and frequent cross-reactions in commercially available antibody detection ELISA assays for Taenia solium cysticercosis. ( 29160912 )
2018
9
Cysticercosis in Shandong Province, Eastern China. ( 29350149 )
2018
10
Transplastomic plants yield a multicomponent vaccine against cysticercosis. ( 29253519 )
2018
11
Analysis of Clinical Profile, Investigation, and Management of Ocular Cysticercosis Seen at a Tertiary Referral Centre. ( 29308965 )
2018
12
Mapping occurrence of Taenia solium taeniosis/cysticercosis and areas at risk of porcine cysticercosis in Central America and the Caribbean basin. ( 28923090 )
2017
13
Raceomose spinal cysticercosis. ( 28799816 )
2017
14
Present status of laboratory diagnosis of human taeniosis/cysticercosis in Europe. ( 28669015 )
2017
15
Two cases of pulmonary cysticercosis manifesting as pleural effusion: case report and literature review. ( 28932584 )
2017
16
Solitary Head and Neck Cysticercosis: A Series of Rare Cases. ( 29383316 )
2017
17
Human cysticercosis in Portugal: long gone or still contemporary? ( 27697089 )
2017
18
Fine-needle aspiration cytology of cysticercosis in submandibular gland. ( 28932037 )
2017
19
Spontaneously Arrested Transmission of Cysticercosis in a Highly Endemic Village with a Very Low Migration Rate. ( 29260655 )
2017
20
Primary Intradural Extramedullary Cervical Spinal Cysticercosis. ( 28711534 )
2017
21
Cysticercosis of the eye. ( 28861361 )
2017
22
Mapping the residual incidence of taeniasis and cysticercosis in Colombia, 2009-2013, using geographical information systems: Implications for public health and travel medicine. ( 29288739 )
2017
23
Isolated primary intradural extramedullary spinal cysticercosis. ( 28681771 )
2017
24
Subcutaneous cysticercosis and cytological findings. ( 28937399 )
2017
25
Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group. ( 28449318 )
2017
26
Cysticercosis: Reiterating the role of cytodiagnosis. ( 28846198 )
2017
27
Assessing Ultrasonography as a Diagnostic Tool for Porcine Cysticercosis. ( 28056028 )
2017
28
Liquid silicone injection in the chest wall simulating cysticercosis. ( 29160386 )
2017
29
High prevalence of bovine cysticercosis found during evaluation of different post-mortem detection techniques in Belgian slaughterhouses. ( 28917298 )
2017
30
Spatial distribution of bovine cysticercosis-A retrospective study in Brazil from 2010 through 2015. ( 28903870 )
2017
31
Survey of Obstetrician-Gynecologists in the United States About Taeniasis and Cysticercosis. ( 28077749 )
2017
32
An epidemiological survey of porcine cysticercosis in Nyasa District, Ruvuma Region, Tanzania. ( 29167825 )
2017
33
Cardiac cysticercosis: A rare cause of myocardial infarction. ( 29157929 )
2017
34
Subcutaneous cysticercosis presenting as cervical swelling: Amazing and unexpected cytological findings. ( 28631659 )
2017
35
Changes in the seroprevalence of cysticercosis in suspected patients in Chandigarh, India between 1998 and 2014: analysis of 17 years of data. ( 28091347 )
2017
36
In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis. ( 28914356 )
2017
37
Herd-level spatial cluster analysis of bovine cysticercosis in the state of ParaA-ba, northeastern Brazil. ( 28658414 )
2017
38
First case of human peritoneal cysticercosis mimicking peritoneal carcinosis: necessity of laparoscopy and histologic assessment for the correct diagnosis. ( 29026624 )
2017
39
A systematic review of taeniasis, cysticercosis and trichinellosis in Vietnam. ( 28320455 )
2017
40
Risk factors, perceptions and practices associated with Taenia solium cysticercosis and its control in the smallholder pig production systems in Uganda: a cross-sectional survey. ( 28049444 )
2017
41
Neglected Intraocular Cysticercosis. ( 28910450 )
2017
42
Target product profiles for the diagnosis of Taenia solium taeniasis, neurocysticercosis and porcine cysticercosis. ( 28892472 )
2017
43
Back Pain and Spinal Cysticercosis. ( 27868401 )
2017
44
Piloting the effectiveness of pig health education in combination with oxfendazole treatment on prevention and/or control of porcine cysticercosis, gastrointestinal parasites, African swine fever and ectoparasites in AngA^nia District, Mozambique. ( 29139069 )
2017
45
Re-visiting the detection of porcine cysticercosis based on full carcass dissections of naturally Taenia solium infected pigs. ( 29145875 )
2017
46
Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe. ( 28732550 )
2017
47
Cysticercosis of the eyelid. ( 28851727 )
2017
48
Unilateral lateral rectus cysticercosis presenting as Duane retraction syndrome type IIb. ( 28084290 )
2017
49
Spontaneous extrusion of subconjunctival cysticercosis cyst. ( 28784914 )
2017
50
Abdominal Cysticercosis in a Red Fox ( Vulpes vulpes ). ( 27749195 )
2017

Variations for Cysticercosis

Expression for Cysticercosis

Search GEO for disease gene expression data for Cysticercosis.

Pathways for Cysticercosis

Pathways related to Cysticercosis according to GeneCards Suite gene sharing:

(show all 36)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.69 IL12B IL18 IL1B IL6 TLR4
2
Show member pathways
12.6 IL12B IL18 IL1B IL6
3
Show member pathways
12.51 IL12B IL18 IL1B IL6 TLR4
4
Show member pathways
12.48 IL12B IL18 IL1B IL6
5
Show member pathways
12.43 IL12B IL1B IL6 TLR4
6
Show member pathways
12.19 IL1B IL6 MIF TLR4
7
Show member pathways
12.08 IL12B IL18 IL1B IL6
8 12.08 IL12B IL18 IL1B IL6 TLR4
9
Show member pathways
12.06 IL1B IL6 TLR4
10 11.93 IL1B IL6 MIF TLR4
11 11.89 IL12B IL18 IL1B IL6
12
Show member pathways
11.88 IL12B IL18 IL1B
13 11.81 IL12B IL1B IL6 TLR4
14
Show member pathways
11.78 IL12B IL6 TLR4
15
Show member pathways
11.77 IL12B IL1B IL6 TLR4
16 11.75 IL18 IL1B IL6 TLR4
17 11.71 IL18 IL1B IL6 TLR4
18 11.64 IL12B IL1B IL6 TLR4
19 11.62 IL6 PDCD1LG2 TLR4
20 11.59 IL12B IL1B IL6
21
Show member pathways
11.59 IL1B IL6 MIF
22 11.4 IL12B IL18 IL1B IL6
23
Show member pathways
11.37 IL12B IL18 IL1B IL6 TLR4
24 11.36 IL18 IL1B IL6 TLR4
25 11.3 IL1B IL6 TLR4
26 11.3 IL12B IL18 IL1B TLR4
27 11.21 IL12B IL1B IL6
28 11.13 IL12B IL18 IL1B IL6
29 11.1 IL12B IL18 IL1B IL6
30 11.06 IL18 IL1B
31 11 IL18 IL1B
32 10.96 IL12B IL18 IL1B IL6
33 10.76 IL12B IL18 IL1B IL6 TLR4
34 10.73 IL1B IL6
35 10.72 MIF TLR4
36 10.47 IL18 IL1B

GO Terms for Cysticercosis

Biological processes related to Cysticercosis according to GeneCards Suite gene sharing:

(show all 37)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.95 IL18 IL1B IL6 PDCD1LG2 TLR4
2 positive regulation of gene expression GO:0010628 9.94 IL18 IL1B IL6 TLR4
3 cell proliferation GO:0008283 9.93 IL12B IL18 MIF TACSTD2
4 regulation of receptor activity GO:0010469 9.93 IL12B IL18 IL1B IL6 MIF
5 inflammatory response GO:0006954 9.85 IL18 IL1B IL6 MIF TLR4
6 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.82 IL1B IL6 TLR4
7 cellular response to lipopolysaccharide GO:0071222 9.81 IL12B IL6 TLR4
8 defense response to Gram-negative bacterium GO:0050829 9.78 IL12B IL6 TLR4
9 positive regulation of inflammatory response GO:0050729 9.77 IL12B IL18 TLR4
10 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.75 IL12B IL18 IL6
11 positive regulation of tumor necrosis factor production GO:0032760 9.7 IL12B MIF TLR4
12 positive regulation of interleukin-6 production GO:0032755 9.69 IL1B IL6 TLR4
13 protein homotrimerization GO:0070207 9.67 DUT MIF
14 positive regulation of interleukin-8 production GO:0032757 9.67 IL1B TLR4
15 negative regulation of interferon-gamma production GO:0032689 9.67 PDCD1LG2 TLR4
16 positive regulation of T cell proliferation GO:0042102 9.67 IL12B IL1B IL6 PDCD1LG2
17 positive regulation of activated T cell proliferation GO:0042104 9.66 IL12B IL18
18 positive regulation of interleukin-12 production GO:0032735 9.66 IL12B TLR4
19 positive regulation of interleukin-10 production GO:0032733 9.65 IL12B TLR4
20 natural killer cell activation GO:0030101 9.65 IL12B IL18
21 positive regulation of chemokine production GO:0032722 9.64 IL6 TLR4
22 negative regulation of interleukin-10 production GO:0032693 9.62 IL12B PDCD1LG2
23 positive regulation of interleukin-17 production GO:0032740 9.62 IL12B IL18
24 negative regulation of interleukin-17 production GO:0032700 9.61 IL12B TLR4
25 lipopolysaccharide-mediated signaling pathway GO:0031663 9.61 IL18 IL1B TLR4
26 positive regulation of lymphocyte proliferation GO:0050671 9.6 IL12B TLR4
27 interleukin-6 production GO:0032635 9.58 IL18 IL1B
28 positive regulation of natural killer cell proliferation GO:0032819 9.57 IL12B IL18
29 positive regulation of tissue remodeling GO:0034105 9.56 IL12B IL18
30 T-helper 1 type immune response GO:0042088 9.5 IL12B IL18 TLR4
31 T-helper 1 cell cytokine production GO:0035744 9.49 IL12B IL18
32 positive regulation of NK T cell proliferation GO:0051142 9.48 IL12B IL18
33 interferon-gamma production GO:0032609 9.43 IL12B IL18 TLR4
34 interferon-gamma biosynthetic process GO:0042095 9.4 IL12B IL18
35 positive regulation of granulocyte macrophage colony-stimulating factor production GO:0032725 9.33 IL12B IL18 IL1B
36 positive regulation of interferon-gamma production GO:0032729 9.26 IL12B IL18 IL1B TLR4
37 positive regulation of NF-kappaB import into nucleus GO:0042346 8.92 IL12B IL18 IL1B TLR4

Molecular functions related to Cysticercosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.02 IL12B IL18 IL1B IL6 MIF
2 cytokine receptor binding GO:0005126 8.96 IL12B MIF

Sources for Cysticercosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....